President & Immunovant CEO
Mon, Jan 12, 2026
Jan 12
200,000 shares @ $3.85
Increased holdings by +12.10%
94th largest trade (out of 285)
Trade made by an officer
10b5-1 scheduled trade
34% win rate · -5.8% median edge vs SPY (80 trades, 90-day)
Insider trade was 83% below market price
Price 52% above 200-day moving average